Validation of the Prognosis for Prolonged Ventilation (ProVent) score in patients receiving 14days of mechanical ventilation
Copyright © 2017 Elsevier Inc. All rights reserved..
PURPOSE: To evaluate the performance of the Prognosis for Prolonged Ventilation (ProVent) 14 score in patients requiring prolonged mechanical ventilation (PMV).
MATERIALS AND METHODS: Data were obtained from 366 patients receiving at least 14days of MV between January 2011 and December 2015 at a university-affiliated tertiary care hospital in Korea. ProVent 14 scores were assessed using the six standard variables. Model discrimination was assessed with the area under the receiver operating characteristic curve. Kaplan-Meier estimates were stratified according to the ProVent 14 score to predict 1-year survival.
RESULTS: The median age of the study group was 62years (range, 50-72years); 65% were male, and medical patients comprised 66% of the group. Overall mortality at 1year was 43%. For ProVent 14 scores ranging from 0 to ≥4, 1-year mortality rates were 7%, 22%, 41%, 52%, and 75%, respectively (log-rank test, P<0.001). The area under the receiver operating characteristic curve of the ProVent 14 score predicting 1-year mortality was 0.74 (95% confidence interval, 0.69-0.78).
CONCLUSIONS: The ProVent 14 score accurately identified patients receiving PMV with a high 1-year mortality risk. Further validation in a larger sample is required.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:44 |
|---|---|
| Enthalten in: |
Journal of critical care - 44(2018) vom: 15. Apr., Seite 249-254 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kim, Won-Young [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Journal Article |
|---|
| Anmerkungen: |
Date Completed 08.03.2019 Date Revised 10.12.2019 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jcrc.2017.11.029 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM278678076 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM278678076 | ||
| 003 | DE-627 | ||
| 005 | 20231225021152.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jcrc.2017.11.029 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0928.xml |
| 035 | |a (DE-627)NLM278678076 | ||
| 035 | |a (NLM)29202432 | ||
| 035 | |a (PII)S0883-9441(17)31672-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kim, Won-Young |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Validation of the Prognosis for Prolonged Ventilation (ProVent) score in patients receiving 14days of mechanical ventilation |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.03.2019 | ||
| 500 | |a Date Revised 10.12.2019 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2017 Elsevier Inc. All rights reserved. | ||
| 520 | |a PURPOSE: To evaluate the performance of the Prognosis for Prolonged Ventilation (ProVent) 14 score in patients requiring prolonged mechanical ventilation (PMV) | ||
| 520 | |a MATERIALS AND METHODS: Data were obtained from 366 patients receiving at least 14days of MV between January 2011 and December 2015 at a university-affiliated tertiary care hospital in Korea. ProVent 14 scores were assessed using the six standard variables. Model discrimination was assessed with the area under the receiver operating characteristic curve. Kaplan-Meier estimates were stratified according to the ProVent 14 score to predict 1-year survival | ||
| 520 | |a RESULTS: The median age of the study group was 62years (range, 50-72years); 65% were male, and medical patients comprised 66% of the group. Overall mortality at 1year was 43%. For ProVent 14 scores ranging from 0 to ≥4, 1-year mortality rates were 7%, 22%, 41%, 52%, and 75%, respectively (log-rank test, P<0.001). The area under the receiver operating characteristic curve of the ProVent 14 score predicting 1-year mortality was 0.74 (95% confidence interval, 0.69-0.78) | ||
| 520 | |a CONCLUSIONS: The ProVent 14 score accurately identified patients receiving PMV with a high 1-year mortality risk. Further validation in a larger sample is required | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Validation Study | |
| 650 | 4 | |a Mortality | |
| 650 | 4 | |a Prognosis | |
| 650 | 4 | |a Respiration, artificial | |
| 650 | 4 | |a Risk | |
| 700 | 1 | |a Jo, Eun-Jung |e verfasserin |4 aut | |
| 700 | 1 | |a Eom, Jung Seop |e verfasserin |4 aut | |
| 700 | 1 | |a Mok, Jeongha |e verfasserin |4 aut | |
| 700 | 1 | |a Kim, Mi-Hyun |e verfasserin |4 aut | |
| 700 | 1 | |a Kim, Ki Uk |e verfasserin |4 aut | |
| 700 | 1 | |a Park, Hye-Kyung |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Min Ki |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Kwangha |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of critical care |d 1987 |g 44(2018) vom: 15. Apr., Seite 249-254 |w (DE-627)NLM074731068 |x 1557-8615 |7 nnns |
| 773 | 1 | 8 | |g volume:44 |g year:2018 |g day:15 |g month:04 |g pages:249-254 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jcrc.2017.11.029 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 44 |j 2018 |b 15 |c 04 |h 249-254 | ||